Nvidia Deepens Push Into Drug Discovery Via New Partnerships with Lilly, Thermo Fisher & More
Back to News
AlphaMaven Alternative Investment News
Hedge Fund

Nvidia Deepens Push Into Drug Discovery Via New Partnerships with Lilly, Thermo Fisher & More

dealbreaker
5 months ago
62 views
On Monday, AI powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference by announcing new and expanded partnerships aimed at embedding AI even deeper into drug discovery and pharmaceutical research.Most notably, Nvidia is teaming up with Eli Lilly to launch a joint innovation lab in South San Francisco. The partners said the lab’s overarching goal is to accelerate drug discovery by applying advanced AI models to longstanding biotech challenges.The lab will bring together Lilly’s...

Continue Reading

Sign up for FREE to read the full article and access 132K+ alternative investment headlines.

Create Free Account Login

Not a member yet?

Why AlphaMaven

The Premier Alternative
Investment Platform

Research & Due Diligence for Qualified Investors

Free Membership for Qualified Investors & Industry Participants
Personalized Content
Breaking News 24/7
Daily Newsletter & Indices
Investment Listings
Company & Contact Directory
Member Publications
Alpha University Videos
AUM Accelerator Program
Due Diligence, Webinars, Events & LeaderBoards
145K+
News & Posts
24K+
Investor Profiles
24/7
Coverage
Sign Up Now

ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.

© 2026 Maven Data Group, Inc.